US brand comparison

Saxenda vs Wegovy

Last updated

Saxenda contains liraglutide. Wegovy contains semaglutide. Compare approved uses, formulations, and self-pay prices.

Saxenda vs Wegovy: the lowest prices now

Saxenda vs Wegovy: active ingredients, formulations, and manufacturers
CompareSaxendaWegovy
Active ingredientLiraglutideGLP-1SemaglutideGLP-1
How it is taken

Injection

Once daily

Injection

Once weekly

Tablet

Once daily, on an empty stomach

ManufacturerNovo NordiskNovo Nordisk
Direct evidence

What was actually compared

No direct trial comparing these exact brands is included in our reviewed catalog. Results from separate trials are not a direct comparison of these products.

Weight-loss results by formulation

Each result belongs to its named trial and dose. Separate trials have different participants and methods; these figures are not a direct comparison.

Saxenda vs Wegovy: sourced weight-loss results by formulation
CompareSaxendaWegovy
Injection evidence
−8% (nejm.org/doi/full/10.1056/NEJMoa1411892) (-8.0% at 56 wks · SCALE Obesity · 3.0 mg daily (Saxenda))

SCALE Obesity · -8.0% at 56 wks (nejm.org)

3.0 mg daily (Saxenda)

Analysis not classified; see trial methods

−14.9% (nejm.org/doi/full/10.1056/NEJMoa2032183) (-14.9% at 68 wks · STEP 1 · 2.4 mg weekly (Wegovy))

STEP 1 · -14.9% at 68 wks (nejm.org)

2.4 mg weekly (Wegovy)

Accounts for treatment discontinuation

Tablet evidence

No reviewed weight-loss result for this brand and formulation.

−13.6% (nejm.org/doi/full/10.1056/NEJMoa2500969) (-13.6% at 64 wks · OASIS 4 · 25 mg daily (Wegovy tablet))

OASIS 4 · -13.6% at 64 wks (nejm.org)

25 mg daily (Wegovy tablet)

Accounts for treatment discontinuation

Product-specific costs

Entry price and maintenance price

Self-pay quotes, not insurance estimates. Each figure identifies the product, provider, and dose where published.

Saxenda vs Wegovy: published self-pay prices by formulation
CompareSaxendaWegovy
Injection prices

Advertised entry price

from $349/mo (healifynow.com/saxenda)

Billed per month; days of supply not on record, so ordered as four weekly doses.

Checked on healifynow.com

Saxenda via HealifyNow

HHealifyNow · seller's own price

its Saxenda page says "From $349/month" for Saxenda (liraglutide 3 mg, weight management), and "Your first consultation is free. No insurance needed, and you only pay if you start treatment." On the same page, "Can I cancel my Saxenda plan at any time?" is answered "Yes. There are no contracts, and you can cancel from your patient portal."

Price conditions

its Saxenda page says "From $349/month" for Saxenda (liraglutide 3 mg, weight management), and "Your first consultation is free. No insurance needed, and you only pay if you start treatment." On the same page, "Can I cancel my Saxenda plan at any time?" is answered "Yes. There are no contracts, and you can cancel from your patient portal."

A starting price: the page does not say what the figure includes or how it changes with the dose; the page prices it per month with no contracts. Its pages also list "Liraglutide From $149/mo" without saying which kind of liraglutide it is. FDA-approved product.

Published maintenance dose

~$1,309 per 5 pens (rxsaver.com/drugs/saxenda)

30-day supply (dailymed.nlm.nih.gov)

$1,308.68 per 30 days at this quoted rate

Checked on rxsaver.com

At 3 mg

Saxenda pens (RxSaver coupon)

RRxSaver · seller's own price

Published price at 3 mg

Third-party reported price
Price conditions

Published price at 3 mg

A discount card, not insurance. Five pens hold 90 mg: 30 days at the 3 mg daily dose. Prices vary by pharmacy and location.

Five pens hold 90 mg: 30 days at the 3 mg daily dose.

30-day supply

Advertised entry price

$199/fill initially (novocare.com/pharmacy/wegovy.html)

28-day supply (novocare.com)

≈ $213.21 per 30 days at this quoted rate

Offer through

Checked on novocare.com

Wegovy pen (standard doses 0.25-2.4 mg)

NovoCare (Novo Nordisk) · maker's own price

first two 28-day fills at 0.25 or 0.5 mg for new patients; NovoCare: "Offer is for 2 monthly fills through December 31, 2026"

Price conditions

first two 28-day fills at 0.25 or 0.5 mg for new patients; NovoCare: "Offer is for 2 monthly fills through December 31, 2026"

After the introductory offer, standard doses cost $349 per box of four pens, a 28-day supply. Wegovy HD (7.2 mg) is $399. Introductory fills must ship by Jan 31, 2027. Eligibility and restrictions apply.

28-day supply

Published maintenance dose

$349/28 days (novocare.com/pharmacy/wegovy.html)

28-day supply (novocare.com)

≈ $373.93 per 30 days at this quoted rate

Checked on novocare.com

At 2.4 mg

Wegovy pen (standard doses 0.25-2.4 mg)

NovoCare (Novo Nordisk) · maker's own price

Published price at 2.4 mg

Price conditions

Published price at 2.4 mg

After the introductory offer, standard doses cost $349 per box of four pens, a 28-day supply. Wegovy HD (7.2 mg) is $399. Introductory fills must ship by Jan 31, 2027. Eligibility and restrictions apply.

One price for every standard dose (0.25-2.4 mg).

28-day supply

Tablet prices

No reviewed tablet formulation in this brand record.

Advertised entry price

from $149/mo (wegovy.com/obesity/what-to-pay-for-wegovy.html)

30-day supply (wegovy.com)

$149 per 30 days at this quoted rate

Checked on wegovy.com

Wegovy pill (oral semaglutide)

NovoCare (Novo Nordisk) · maker's own price

Wegovy pill self-pay at the lowest dose: "Patients pay $149 for each month of 1.5 mg, and $199 per month for 4 mg and $299 per month for 9 mg and 25 mg. One month defined as 1 bottle of 30 tablets."

Price conditions

Wegovy pill self-pay at the lowest dose: "Patients pay $149 for each month of 1.5 mg, and $199 per month for 4 mg and $299 per month for 9 mg and 25 mg. One month defined as 1 bottle of 30 tablets."

$149/mo for 1.5 mg; $199 for 4 mg; $299 for 9 mg and 25 mg. Its plan is one month at a time: "One month defined as 1 bottle of 30 tablets." The Wegovy pen and Ozempic pen offers are left as listed (an introductory price for two fills, then a per-month price).

30-day supply

Published maintenance dose

$299/mo (wegovy.com/obesity/what-to-pay-for-wegovy.html)

30-day supply (wegovy.com)

$299 per 30 days at this quoted rate

Checked on wegovy.com

At 25 mg

Wegovy pill (oral semaglutide)

NovoCare (Novo Nordisk) · maker's own price

Published price at 25 mg

Price conditions

Published price at 25 mg

$149/mo for 1.5 mg; $199 for 4 mg; $299 for 9 mg and 25 mg. Its plan is one month at a time: "One month defined as 1 bottle of 30 tablets." The Wegovy pen and Ozempic pen offers are left as listed (an introductory price for two fills, then a per-month price).

$149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg).

30-day supply

How these quotes are selected

For each price basis, we prefer a recently checked manufacturer-direct quote, then a recently checked provider quote for that brand and formulation. Within each group, documented 30-day costs come first, lowest to highest. Quotes without a documented supply period have no cost rank. Older quotes appear as dated references only when no current quote is tracked. Providers may differ between entry and maintenance prices. Missing maintenance prices are never replaced with entry prices. Compounded products, combined brand quotes, and membership-only fees are excluded. Prices at different doses are not equivalent treatment costs; confirm supply length, eligibility, and added fees.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted maintenance dose is not a dosing recommendation. Our methodology

From each FDA label

Saxenda vs Wegovy side effects

Rate on the medicine, with the placebo rate in brackets, at the highest dose in each label's table. These come from separate trials, so they are not a head-to-head comparison.

Side effectSaxenda SAXENDAWegovy 2.4 mg
Nausea39.3% (13.8%)44% (16%)
Diarrhea20.9% (9.9%)30% (16%)
Vomiting15.7% (3.9%)24% (6%)
Constipation19.4% (8.5%)24% (11%)
Abdominal pain5.4% (3.1%)20% (10%)
Indigestion9.6% (2.7%)9% (3%)
Fatigue7.5% (4.6%)11% (5%)
Headache13.6% (12.6%)14% (10%)
Dizziness6.9% (5%)8% (4%)
Injection site reactions13.9% (10.5%)not in table
Burping4.5% (0.2%)not in table
Reflux4.7% (1.7%)5% (3%)
Gas4% (2.5%)6% (4%)
Bloating4.5% (3%)7% (5%)
Hair lossnot in table3% (1%)
From FDA and CMS records

Saxenda vs Wegovy: timing, generics and coverage

Read from each FDA label, FDA's Orange Book and CMS's Part D files, and updated when they change.

BrandSoonest top doseHalf-lifeGeneric approved?Patent on the medicine toOn Medicare Part D, 2025
Wegovy7.2 mg from week 21about 1 weekNoDec 5, 2031108,843
Saxenda3 mg from week 5about 13 hoursYes, 3None listedNone listed

How long each takes · Generics and patents · Who covers what

US prescribing information

Approved uses by formulation

Eligibility, contraindications, and warnings are in each product's full prescribing information.

Saxenda vs Wegovy: reviewed approved uses by formulation
CompareSaxendaWegovy
Injection

Weight management in adults and children 12+ with obesity and body weight over 60 kg; adults with overweight and a weight-related condition.

US prescribing information (novo-pi.com) (Saxenda Injection prescribing information)

Reviewed Nov 4, 2026

Weight management in eligible adults and adolescents 12+ with obesity; cardiovascular risk reduction in eligible adults; noncirrhotic MASH with moderate to advanced liver fibrosis in adults (accelerated approval).

US prescribing information (novo-pi.com) (Wegovy Injection prescribing information)

Reviewed Nov 4, 2026

Tablet

No reviewed tablet label in this brand record. Ingredient record

Weight management and cardiovascular risk reduction in eligible adults. The tablet is not labeled for MASH or pediatric use.

US prescribing information (novo-pi.com) (Wegovy Tablet prescribing information)

Reviewed Nov 4, 2026

Full evidence and safety information

Compare the active ingredients
Updated automatically

What changed for Saxenda and Wegovy

  • PriceCorrected: Telezen MD, Compounded semaglutide via Telezen MD, $128/mo on its own page (we had from $89/mo) (read on telezenmd.com)
  • PriceCorrected: Ascend Vitality, Compounded semaglutide via Ascend Vitality, $149/mo on its own page (we had from $89/mo) (read on av-life.com)
  • PriceNexLife: Microdose semaglutide via NexLife now $109/mo (was $129/mo) (read on nexlife.com)
  • PriceRow Telehealth: Compounded semaglutide dissolving tablets (ODT) via Row Telehealth now $139/mo (was from $139/mo) (read on rowtelehealth.com)
  • PriceRow Telehealth: Compounded semaglutide via Row Telehealth now $129/mo (was from $129/mo) (read on rowtelehealth.com)
  • TrialResults posted for a Liraglutide study: SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity (clinicaltrials.gov/study/NCT04775082)

Written from each source's own record as it changes. Every change on GLPcompare

Questions

Saxenda vs Wegovy: common questions

Is Saxenda the same as Wegovy?

No. Saxenda contains liraglutide and Wegovy contains semaglutide, which are different medicines.

Is Saxenda or Wegovy better for weight loss?

No trial on our list compared them directly. In separate trials: Saxenda -8.0% at 56 wks in SCALE Obesity (3.0 mg daily (Saxenda)) (nejm.org); Wegovy -14.9% at 68 wks in STEP 1 (2.4 mg weekly (Wegovy)) (nejm.org). Separate trials enrolled different people for different lengths of time, so these figures cannot rank them.

Is Saxenda or Wegovy safer?

We know of no trial set up to answer that. Stopping because of side effects, each in its own trial and not a head-to-head figure: Saxenda 9.8% vs 4.3% placebo (3.0 mg) (FDA Saxenda label, pooled 3.0 mg obesity trials (SCALE)) (accessdata.fda.gov); Wegovy 7.0% vs 3.1% placebo (STEP 1 (2.4 mg, 68 wks, obesity)) (nejm.org). Each FDA label lists its own warnings, and which ones matter depends on your health. Side effects compared, from each FDA label

What Wegovy dose is equivalent to Saxenda?

No FDA label sets a dose of Saxenda that equals a dose of Wegovy, and we know of no trial that defines one. Switching is a prescriber's decision, and each label sets its own starting dose and steps. Each label's doses and steps

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.